Institutional members access full text with Ovid®

Share this article on:

Vasopressin in pediatric shock and cardiac arrest

Choong, Karen MB, BCh; Kissoon, Niranjan MD

Pediatric Critical Care Medicine: July 2008 - Volume 9 - Issue 4 - pp 372-379
doi: 10.1097/PCC.0b013e318172d7c8
Feature Review Article

Objective: To review the physiology and the published literature on the role of vasopressin in shock in children.

Data Source: We searched MEDLINE (1966–2007), EMBASE (1980–2007), and the Cochrane Library, using the terms vasopressin, terlipressin, and shock and synonyms or related terms for relevant studies in pediatrics. We searched the online ISRCTN-Current Controlled Trials registry for ongoing trials. We reviewed the reference lists of all identified studies and reviews as well as personal files to identify other published studies.

Results: Beneficial effects have been reported in vasodilatory shock and asystolic cardiac arrest in adults. Solid evidence for vasopressin use in children is scant. Observational studies have reported an improvement in blood pressure and rapid weaning off catecholamines during administration of low-dose vasopressin. Dosing in children is extrapolated from adult studies.

Conclusions: Vasopressin offers promise in shock and cardiac arrest in children. However, in view of the limited experience with vasopressin, it should be used with caution. Results of a double-blind, randomized controlled trial in children with vasodilatory shock will be available soon.

From Pediatric Critical Care and Neonatology, McMaster Children's Hospital, Hamilton, Ontario, Canada (KC); and Acute and Critical Care Programs, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada (NK).

The authors have not disclosed any potential conflicts of interest.

For information regarding this article, E-mail: choongk@mcmaster.ca

©2008The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies